Adrenoleukodystrophy

J Gordon Millichap

doi:10.15844/pedneurbriefs-3-12-1

Adrenoleukodystrophy

Pediatric Neurology Briefs

Volume 3 (1989): Issue 12

By: J Gordon Millichap

Open Access

|Dec 1989

Abstract

The biochemical and clinical efficacy of dietary erucic acid (C22:1) therapy for X-l inked adrenoleukodystrophy (ALD) was investigated at the Departments of Pediatrics, Human Genetics, Neurology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, and the Department of Neurology, University of California, Davis, Sacramento, CA.

References

Rizzo WB Leshner RT Odone A Dammann AL Craft DA Jensen ME Dietary erucic acid therapy for X-linked adrenoleukodystrophy Neurology 1989 Nov 39 11 1415 22 10.1212/WNL.39.11.1415 2682348
Open DOI Search in Google Scholar Back to article
Sadeghi-Nejad A Senior B Adrenomyeloneuropathy presenting as Addison's disease in childhood N Engl J Med 1990 Jan 4 322 1 13 6 10.1056/NEJM199001043220103 2294415
Open DOI Search in Google Scholar Back to article
Aubourg P Sellier N Chaussain JL Kalifa G MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy Neurology 1989 Dec 39 12 1619 21 10.1212/WNL.39.12.1619 2586779
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-3-12-1 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 89 - 90

Published on: Dec 1, 1989

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Adrenoleukodystrophy,

Plasma Sphingomyelin,

Adrenomyelo-Neuropathy

© 1989 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 3 (1989): Issue 12